Coupled with TNBC's aggressive biology, high rate of early recurrence, and tendency to metastasize to vital organs like the brain and lungs, long-term outcomes were historically poor.

For patients with early-stage triple-negative breast cancer (TNBC), finishing chemotherapy and surgery should feel like the end of the hardest chapter. But for many, it marks the beginning of a ...

Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.

There is a promising shift toward nonsurgical treatment strategies in early breast cancer, as clinicians aim to reduce harm ...

Datroway significantly improves overall and progression-free survival in metastatic triple-negative breast cancer patients ineligible for immunotherapy. TROPION-Breast02 trial results highlight ...

Triple-negative breast cancer lacks key receptors, requiring chemotherapy, immunotherapy, surgery, and radiation, with treatment tailored to cancer stage. Early-stage TNBC treatment often involves ...

AstraZeneca and Gilead have won approval for treatments of an advanced form of the disease.

When Chase Johnson was 31, her dog began acting strange. He was anxious, wouldn't leave her side and, one day, pushed his nose into the side of her breast. Johnson felt a hard lump. "I wasn't someone ...

Hearing the words "triple-negative breast cancer" (TNBC) can be overwhelming. It's a diagnosis that sounds heavy — not just because breast cancer itself is frightening, but because this particular ...

Patients facing advanced triple‑negative breast cancer (TNBC) know how unforgiving this disease can be, especially when immunotherapy isn’t an option. Now, following the Food and Drug Administration’s ...